Suppr超能文献

单核RNA测序揭示肺泡巨噬细胞是肥胖型射血分数保留的心力衰竭相关肺动脉高压中内皮损伤的驱动因素。

Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertension.

作者信息

Gorica Era, Spezzini Jacopo, Papadopoulou Iliana, Telesca Marialucia, Masciovecchio Valeria, Moahmmed Shafeeq A, Mengozzi Alessandro, Cheng Hung-Wei, Atzemian Natalia, Di Venanzio Ludovica, Mongelli Alessia, Dzemali Omer, Calderone Vincenzo, Paneni Francesco, Matter Christian M, Ludewig Burkhard, Ruschitzka Frank, Costantino Sarah

机构信息

Center for Translational and Experimental Cardiology (CTEC), Department of Cardiology, University Hospital Zurich and University of Zürich, Wagistrasse 12, 8952, Schlieren, Switzerland.

Department of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland.

出版信息

Cardiovasc Diabetol. 2025 Jul 3;24(1):268. doi: 10.1186/s12933-025-02772-y.

Abstract

BACKGROUND

Pulmonary hypertension (PH) is a frequent complication in obese patients showing heart failure with preserved ejection fraction (HFpEF) and correlates with poor prognosis. PH associated with cardiometabolic HFpEF (PH-cHFpEF) is characterized by inflammation and metabolic dysregulation. Alterations in the immune landscape, particularly activation of alveolar macrophages (AMs), may propagate the inflammatory response and lead to endothelial damage and vascular remodeling in the lung. Whether AMs contribute to PH in cardiometabolic HFpEF remains elusive.

PURPOSE

The present study investigates the role of alveolar macrophages in PH-cHFpEF.

METHODS

Mice subjected to high-fat diet and L-NAME treatment for 15 weeks were used as experimental model of PH-cHFpEF. At the end of the treatment, echocardiography and treadmill exhaustion tests were performed. Single nucleus RNA-sequencing (snRNA-seq) was employed to study the AMs transcriptional landscape and cell-cell interactions. In vitro experiments were performed to study the mechanisms underlying metabolic stress-induced macrophage dysfunction using palmitic acid (PA), co-culture experiments were used to investigate the crosstalk between macrophages and endothelial cells.

RESULTS

Compared with control mice, PH-cHFpEF animals displayed right ventricular dysfunction, vascular remodeling and increased pulmonary pressure. SnRNA-seq of mouse lungs revealed transcriptional alterations in AMs, with a significant reduction in their abundance in PH-cHFpEF mice. These changes were associated with dysregulation of transcriptional programs involved in pyroptosis, defective autophagy and inflammation in AMs from PH-cHFpEF vs. control mice, as shown by the upregulation of c-Fos, Dusp1, Pim-1 and Ccn1. STRING analysis revealed a molecular link between these partners and highlighted c-Fos/Dusp-1 as a central axis of AMs cell death and inflammation. Metabolic stress induced by PA in isolated murine macrophages recapitulated c-Fos/Dusp-1 activation as well as IL-1β, TNF-α, and Caspase-1 upregulation resulting in inflammation, impaired autophagy and enhanced pyroptosis. Moreover, c-Fos/Dusp1 activation in macrophages promoted secretion of pro-inflammatory chemokines leading to endothelial dysfunction in a paracrine manner. Dusp1 knockdown rescued autophagy and pyroptosis while mitigating macrophage-driven inflammation and endothelial damage.

CONCLUSIONS

PH-cHFpEF is characterized by AMs activation, upregulation of the cFos/Dusp-1 pathway and subsequent pyroptosis and inflammation in alveolar macrophages. Our findings highlight the role of AMs as putative targets for preventing endothelial damage in experimental PH-cHFpEF.

摘要

背景

肺动脉高压(PH)是肥胖患者中常见的并发症,这些患者表现为射血分数保留的心力衰竭(HFpEF),且与不良预后相关。与心脏代谢性HFpEF相关的PH(PH-cHFpEF)的特征是炎症和代谢失调。免疫格局的改变,尤其是肺泡巨噬细胞(AMs)的激活,可能会加剧炎症反应,并导致肺部内皮损伤和血管重塑。AMs是否在心脏代谢性HFpEF的PH中起作用仍不清楚。

目的

本研究探讨肺泡巨噬细胞在PH-cHFpEF中的作用。

方法

将接受高脂饮食和L-NAME治疗15周的小鼠用作PH-cHFpEF的实验模型。治疗结束时,进行超声心动图和跑步机耐力测试。采用单核RNA测序(snRNA-seq)研究AMs的转录格局和细胞间相互作用。进行体外实验,使用棕榈酸(PA)研究代谢应激诱导巨噬细胞功能障碍的机制,共培养实验用于研究巨噬细胞与内皮细胞之间的相互作用。

结果

与对照小鼠相比,PH-cHFpEF动物表现出右心室功能障碍、血管重塑和肺动脉压力升高。小鼠肺组织的snRNA-seq显示AMs存在转录改变,在PH-cHFpEF小鼠中其丰度显著降低。这些变化与PH-cHFpEF小鼠与对照小鼠相比,AMs中涉及焦亡、自噬缺陷和炎症的转录程序失调有关,如c-Fos、Dusp1、Pim-1和Ccn1的上调所示。STRING分析揭示了这些分子之间的联系,并突出了c-Fos/Dusp-1作为AMs细胞死亡和炎症的中心轴。PA在分离的小鼠巨噬细胞中诱导的代谢应激重现了c-Fos/Dusp-1的激活以及IL-1β、TNF-α和Caspase-1的上调,导致炎症、自噬受损和焦亡增强。此外,巨噬细胞中c-Fos/Dusp1的激活以旁分泌方式促进促炎趋化因子的分泌,导致内皮功能障碍。Dusp1基因敲低可挽救自噬和焦亡,同时减轻巨噬细胞驱动的炎症和内皮损伤。

结论

PH-cHFpEF的特征是AMs激活、cFos/Dusp-1途径上调以及随后肺泡巨噬细胞的焦亡和炎症。我们的研究结果突出了AMs作为预防实验性PH-cHFpEF中内皮损伤的潜在靶点的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85b0/12225126/bde150b9e788/12933_2025_2772_Fig1_HTML.jpg

相似文献

3
MHCIILYVE1CCR2 Interstitial Macrophages Promote Medial Fibrosis in Pulmonary Arterioles and Contribute to Pulmonary Hypertension.
Circ Res. 2025 Jun 20;137(1):46-66. doi: 10.1161/CIRCRESAHA.125.326173. Epub 2025 May 13.
4
3D Imaging Reveals Complex Microvascular Remodeling in the Right Ventricle in Pulmonary Hypertension.
Circ Res. 2024 Jun 21;135(1):60-75. doi: 10.1161/CIRCRESAHA.123.323546. Epub 2024 May 21.
7
Management of urinary stones by experts in stone disease (ESD 2025).
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.
9
Chromatin Rewiring by SETD2 Drives Lipotoxic Injury in Cardiometabolic HFpEF.
Circ Res. 2025 May 9;136(10):1079-1095. doi: 10.1161/CIRCRESAHA.124.325310. Epub 2025 Apr 11.
10
The nitrofen/bisdiamine murine model of congenital diaphragmatic hernia has a pulmonary hypertension vascular phenotype consistent with human CDH.
Am J Physiol Lung Cell Mol Physiol. 2025 Jul 1;329(1):L48-L60. doi: 10.1152/ajplung.00233.2024. Epub 2025 May 30.

本文引用的文献

1
LncRNA MEG3 aggravates acute pulmonary embolism-induced pulmonary arterial hypertension by regulating miR-34a-3p/DUSP1 axis.
Int J Biol Macromol. 2024 Dec;283(Pt 3):137755. doi: 10.1016/j.ijbiomac.2024.137755. Epub 2024 Nov 17.
2
Panorama of artery endothelial cell dysfunction in pulmonary arterial hypertension.
J Mol Cell Cardiol. 2024 Dec;197:61-77. doi: 10.1016/j.yjmcc.2024.10.004. Epub 2024 Oct 20.
3
Pyroptosis in health and disease: mechanisms, regulation and clinical perspective.
Signal Transduct Target Ther. 2024 Sep 20;9(1):245. doi: 10.1038/s41392-024-01958-2.
4
Pulmonary hypertension associated to left heart disease: Phenotypes and treatment.
Eur J Intern Med. 2024 Nov;129:1-15. doi: 10.1016/j.ejim.2024.07.030. Epub 2024 Aug 1.
5
Myeloid Cell Derived IL1β Contributes to Pulmonary Hypertension in HFpEF.
Circ Res. 2023 Nov 10;133(11):885-898. doi: 10.1161/CIRCRESAHA.123.323119. Epub 2023 Nov 6.
6
Epigenetic Network in Immunometabolic Disease.
Adv Biol (Weinh). 2024 Jan;8(1):e2300211. doi: 10.1002/adbi.202300211. Epub 2023 Oct 4.
7
Interleukin-6 and pulmonary hypertension: from physiopathology to therapy.
Front Immunol. 2023 Jun 28;14:1181987. doi: 10.3389/fimmu.2023.1181987. eCollection 2023.
8
Metabolic reprogramming, oxidative stress, and pulmonary hypertension.
Redox Biol. 2023 Aug;64:102797. doi: 10.1016/j.redox.2023.102797. Epub 2023 Jun 24.
9
Uncoupled pyroptosis and IL-1β secretion downstream of inflammasome signaling.
Front Immunol. 2023 Apr 6;14:1128358. doi: 10.3389/fimmu.2023.1128358. eCollection 2023.
10
Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation.
Life Sci. 2023 Feb 15;315:121372. doi: 10.1016/j.lfs.2023.121372. Epub 2023 Jan 4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验